covid-19 antigen rapid test products will be on sale in retail pharmacies
antigen detection reagent will be on the shelves soon
In March 11th, the State Council decided to study the joint prevention and control mechanism of New Coronavirus pneumonia. Based on nucleic acid detection, the State Council added antigen detection as a supplement, and formulated the “COVID-19 virus antigen detection application plan” (Trial Implementation). If community residents have independent testing needs, they can purchase antigen testing reagents for rapid testing through retail pharmacies, online sales platforms and other channels.
The reporter of e company learned from Lbx Pharmacy Chain Joint Stock Company(603883) ( Lbx Pharmacy Chain Joint Stock Company(603883) ) that on the 12th, Lbx Pharmacy Chain Joint Stock Company(603883) pharmacy and Guangzhou Guangzhou Wondfo Biotech Co.Ltd(300482) pharmacy reached cooperation. The first batch of covid-19 antigen rapid test products have been distributed in stores and are expected to be sold in stores in the near future. The first batch of products will be delivered to the stores of Lbx Pharmacy Chain Joint Stock Company(603883) pharmacy in 12 provinces and cities including Shanghai, Hunan and Jiangsu
, according to the introduction, the New Coronavirus (2019-nCoV) antigen detection kit (colloidal gold method) purchased by the Lbx Pharmacy Chain Joint Stock Company(603883) pharmacy is one of the five similar products registered by the State Administration of drug administration, which not only applies to the samples of oropharyngeal swabs and nasopharyngeal swabs, but also achieves rapid detection efficiency in 15 minutes.
Lbx Pharmacy Chain Joint Stock Company(603883) president Wang Li told the reporter of E company that after the release of antigen detection, the detection demand is expected to further extend to the active demand. The detection amount of covid-19 may exceed the previous nucleic acid detection amount, driving the rapid improvement of drugstore passenger flow and sales performance, “At the same time, covid-19 virus quick test products can provide focus for pharmacies and help pharmacies transition from drug sales to providing health services.”
In addition, according to media reports, Dashenlin Pharmaceutical Group Co.Ltd(603233) and Guangzhou Wondfo Biotech Co.Ltd(300482) have signed a strategic cooperation agreement on the distribution of covid-19 antigen self-test reagent, and Guangzhou Wondfo Biotech Co.Ltd(300482) covid-19 antigen self-test reagent will be “launched” in Dashenlin Pharmaceutical Group Co.Ltd(603233) offline stores today. Many retail drugstore enterprises interviewed by the reporter of E company said that they had begun to prepare antigen detection reagents urgently.
first batch of 5 approved
Previously, company e reported that the pending information of medical device approval document (change) released on the website of the State Food and Drug Administration on March 12 showed that it was issued by Guangzhou Wondfo Biotech Co.Ltd(300482) , Bgi Genomics Co.Ltd(300676) subsidiary Shenzhen Huada Yinyuan Pharmaceutical Technology Co., Ltd., Beijing jinwofu Bioengineering Technology Co., Ltd., Nanjing Nanjing Vazyme Biotech Co.Ltd(688105) Medical Technology Co., Ltd Five covid-19 antigen detection kits developed by five companies of Beijing huaketai Biotechnology Co., Ltd. have passed the registration information change of the food and drug administration.
5 covid-19 antigen detection kits belong to five companies, of which Guangzhou Wondfo Biotech Co.Ltd(300482) , Shenzhen Huada Yinyuan ( Bgi Genomics Co.Ltd(300676) ), Nanjing Vazyme Biotech Co.Ltd(688105) are all A-share companies, while Beijing jinwofu and Beijing huaketai biology have not yet landed in the capital market. It is worth noting that Beijing huaketai biology disclosed the gem IPO prospectus in 2019, but finally withdrew its application
